We narrowed to 167 results for: mme

1. Anti-GAD1 [BCN49.2.3D1] (Recombinant Antibody)

   Antibody

   #210068-rAb

   Purpose

   Anti-GAD1 (Human) recombinant mouse monoclonal antibody

   Depositor

   CDI Laboratories Inc (CDI) and Melina Fan

   Article

   et al unpublished

   Recommended Applications

   Immunocytochemistry

   Reactivity

   Human

   Source Species

   Mouse

   Isotype

   IgG2a

   Trial Size

   Available to purchase

   Available Since

   Aug. 1, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

2. Anti-Jagged [D5] (Recombinant Antibody)

   Antibody

   #201864-rAb

   Purpose

   Anti-Jagged (Human) recombinant scFv-Fc-fusion

   Depositor

   John McCafferty

   Article

   Schofield et al Genome Biol. 2007;8(11):R254.

   Recommended Applications

   Immunocytochemistry

   Reactivity

   Human

   Source Species

   Human

   Isotype

   IgG1

   Trial Size

   Available to purchase

   Available Since

   Nov. 8, 2023

   Availability

   Industry, Academic Institutions, and Nonprofits

   

3. Anti-Desmin [D7] (Recombinant Antibody)

   Antibody

   #201865-rAb

   Purpose

   Anti-Desmin (Human) recombinant scFv-Fc-fusion

   Depositor

   John McCafferty

   Article

   Schofield et al Genome Biol. 2007;8(11):R254.

   Recommended Applications

   ELISA

   Reactivity

   Human

   Source Species

   Human

   Isotype

   IgG1

   Trial Size

   Available to purchase

   Available Since

   Oct. 11, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

4. Anti-Integrin alpha 5 [IPI-MFR5] (Recombinant Antibody)

   Antibody

   #213671-rAb

   Purpose

   Anti-Integrin α5 (Mouse) chimeric recombinant antibody with fused rat variable and rabbit constant domains; binds α5 subunit.

   Depositor

   Institute for Protein Innovation (IPI)

   Article

   Kinashi et al Blood Cells. 1994;20(1):25-44.

   Recommended Applications

   Flow Cytometry

   Reactivity

   Mouse

   Source Species

   Rabbit

   Isotype

   IgG

   Trial Size

   Not available to purchase

   Available Since

   March 27, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

5. Anti-Integrin alpha 4 [IPI-9C10] (Recombinant Antibody)

   Antibody

   #213670-rAb

   Purpose

   Anti-Integrin α4 (Mouse) chimeric recombinant antibody with fused rat variable and rabbit constant domains; binds α4 subunit.

   Depositor

   Institute for Protein Innovation (IPI)

   Article

   Kinashi et al Blood Cells. 1994;20(1):25-44.

   Recommended Applications

   Flow Cytometry

   Reactivity

   Mouse

   Source Species

   Rabbit

   Isotype

   IgG

   Trial Size

   Not available to purchase

   Available Since

   May 1, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

6. Anti-Integrin alpha L [IPI-M17/4] (Recombinant Antibody)

   Antibody

   #213663-rAb

   Purpose

   Anti-Integrin αL (Mouse) chimeric recombinant antibody with fused rat variable and rabbit constant domains; binds αL subunit.

   Depositor

   Institute for Protein Innovation (IPI)

   Article

   Sanchez-Madrid et al Cell Immunol. 1982 Oct;73(1):1-11. doi:

   Recommended Applications

   Flow Cytometry

   Reactivity

   Mouse

   Source Species

   Rabbit

   Isotype

   IgG

   Trial Size

   Not available to purchase

   Available Since

   March 27, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits

   

7. Anti-Glypican 4 (GPC4) [IPI-mGPC4.9] (Recombinant Antibody)

   Antibody

   #222516-rAb

   Purpose

   Anti-Glypican 4 (Mouse) chimeric recombinant antibody with fused human variable and rabbit constant domains; recognizes mouse and human GPC4. Cross-reacts with mouse GPC6.

   Depositor

   Institute for Protein Innovation (IPI)

   Article

   Institute for Protein et al unpublished

   Recommended Applications

   Flow Cytometry and Immunocytochemistry

   Reactivity

   Human and Mouse

   Source Species

   Rabbit

   Isotype

   IgG

   Trial Size

   Not available to purchase

   Available Since

   Nov. 5, 2024

   Availability

   Industry, Academic Institutions, and Nonprofits